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Two Cases of BCG Osteomyelitis 
Diagnosed Through Polymerase 
Chain Reaction/Electrospray 
Ionization-Mass Spectrometry 
Technology
To the Editor—We echo the views of 
Ozenci et  al. [1] that polymerase chain 
reaction/electrospray ionization-mass 
spectrometry (PCR/ESI-MS) has value 
for broad microbial detection. We used 
PCR/ESI-MS at our hospital until its 
withdrawal and here present 2 cases to 
illustrate its utility.
A 14-month-old boy presented with 
reduced use of the left arm, with no recent 
trauma or fever. His arm was held adducted, 
but the remainder of the examination was 
unremarkable. Magnetic resonance imag-
ing (MRI) showed extensive marrow sig-
nal abnormality in the left humerus. He 
received intravenous co-amoxiclav and was 
discharged on oral co-amoxiclav. Twenty 
days into treatment, with no improve-
ment, he was admitted for bone biopsy and 
intravenous ceftriaxone. Histopathology 
showed mild chronic inflammation with 
giant cells. Bone culture showed no growth. 
Analysis by PCR/ESI-MS unexpectedly 
revealed Mycobacterium tuberculosis 
(MTb) complex. There was no history of 
tuberculosis contact. A tuberculin skin test 
(TST) showed 20  mm induration, but an 
interferon-gamma release assay (IGRA) 
was negative. He initiated rifampicin, 
isoniazid, pyrazinamide, and etham-
butol. Several weeks later, culture revealed 
Mycobacterium bovis BCG, and pyrazina-
mide was stopped. Investigations did not 
reveal an immunodeficiency, and he com-
pleted 1 year of treatment with good reso-
lution of function and no growth arrest in 
the affected bone.
A 9-month-old boy presented with 4 
weeks of pain, fever, and reduced move-
ment at the left elbow. MRI revealed 
osteomyelitis of the proximal radius and 
septic arthritis of the left elbow. A  joint 
washout was followed by intravenous 
co-amoxiclav. Culture of the joint fluid 
and synovium was sterile. Following 
good initial response to treatment, he was 
discharged on oral co-amoxiclav. Three 
weeks later he developed new swelling of 
the left elbow. Imaging showed subluxa-
tion of the proximal radio-ulnar joint and 
a collection within the olecranon fossa. 
Another washout was performed but still 
no organism was identified. Analysis by 
PCR/ESI-MS revealed MTb complex. 
There was no history of tuberculosis con-
tact. A  TST showed 16mm induration, 
but the IGRA was negative. He initiated 
rifampicin, isoniazid, pyrazinamide, and 
ethambutol. Several weeks later, cul-
ture revealed Mycobacterium bovis BCG, 
and pyrazinamide was stopped. Three 
months into treatment, he developed left 
wrist swelling; imaging showed extensive 
multi-focal osteomyelitis, and he initi-
ated subcutaneous gamma-interferon 
(50 mcg/m2 thrice-weekly) with good 
response. A  specific molecular defect in 
the IFN-gamma/IL-12/IL-23 axis could 
not be identified.
In summary, 2 children presented 
with unexpected BCG osteomyelitis, 
which is a rare complication of vacci-
nation and presents nonspecifically, 
often leading to delays in diagnosis [2, 
3]. PCR/ESI-MS enabled identifica-
tion of MTb complex and initiation of 
anti-tuberculous therapy prior to tradi-
tional culture results. In young children, 
prompt initiation of definitive treatment 
may prevent long-term growth plate 
damage. Broad-range molecular test-
ing is therefore a valuable technique, 
and it is regrettable that PCR/ESI-MS 
will no longer facilitate earlier micro-
bial diagnosis. Although the authors 
may be correct in attributing the 
demise of Iridica at least partially to its 
cost ($200–300 per test) [1], the only 
equivalent test developed by Karius [4] 
costs about $2000, has a longer turn-
around time and is currently neither 
Conformité Européene nor Food and 
Drug Administration approved.
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